Healthcare Investment Team

Ryan is a Founding Partner of Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Mike Cooper

Mike is a Founding Partner of Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

John Hennegan

John is a Founding Partner of Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Don Pierce

Don is a Partner at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA

Chris Mioton

Chief of Strategy and Talent Development

Chris is a Partner at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

James E. Forrest

Chairman

James E. Forrest currently serves as Chairman of Shore Capital, a Chicago-based private equity group focused on health care services and the food industry

Michael Burcham

Michael is an entrepreneur, investor and healthcare strategist with 30 years’ experience leading technology-enabled healthcare organizations.

Sean McEnroe

Executive Partner

Sean McEnroe serves on multiple equity backed, multi-site healthcare, start-up, and non-profit boards.

Paul Rutledge

Executive Partner

Paul is an Executive Partner at Shore Capital Partners. He currently serves as a Director for SouthStar Urgent Care and SENTA, Shore Capital portfolio companies. Paul previously served as President and CEO of CHC Holdings, the Chinese health care venture backed by the Frist family. Until retiring in 2013, Paul spent 30 years at HCA, rising to president of its 61-hospital Central Group. Paul joined HCA in 1982 as COO in the company’s New Orleans market and has held a number of leadership positions within the system. Prior to this, He served as President of TriStar Health System from June 1996 to January 2001 and served as President of Centennial Medical Center from May 1993 to June 1996.

Rory Kenny

Principal

Rory is a Principal at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Matt Sweeney

Principal

Matt is a Principal at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Mickey Jiang

Principal

Mickey is a Principal at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA

Jon Tomberlin

Jon is a Senior Associate at Shore Capital, a microcap private equity firm focused on partnering with companies that have $1-10 million of EBITDA.

Mike Oleferchik

Mike is a Senior Associate at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Ankeet Patel

Ankeet is a Senior Associate at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Alex Nevill

Alex is a Senior Associate at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Cole Michalek

Cole is an Associate at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Adam Boudjemai

Adam is an Associate at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Max Martineau

Max is an Associate at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Colin North

Colin is an Associate at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Alex Fordham

Alex is an Analyst at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-$10 million of EBITDA.

John Hazen

John is an Analyst at Shore Capital Partners, a microcap private equity firm focused on partnering with companies that have between $1-$10 million of EBITDA.

Tim Sharky

Tim is an Analyst at Shore Capital Partners, a microcap private equity firm focused on partnering with companies that have between $1-$10 million of EBITDA.

Jack Harrington

Jack is an Analyst at Shore Capital Partners, a microcap private equity firm focused on partnering with companies that have between $1-$10 million of EBITDA.

David Clancy

David is an Analyst at Shore Capital Partners, a microcap private equity firm focused on partnering with companies that have between $1-$10 million of EBITDA.

Nick DeSalvo